These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3054036)

  • 21. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies.
    Dudzinski DM
    Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771
    [No Abstract]   [Full Text] [Related]  

  • 22. The FDA and the fight against terrorism.
    Meadows M
    FDA Consum; 2004; 38(1):20-7. PubMed ID: 15032200
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA: the regulatory process.
    Slutsky AS
    Respir Care; 1995 Sep; 40(9):952-6. PubMed ID: 10152239
    [No Abstract]   [Full Text] [Related]  

  • 24. A century of ensuring safe foods and cosmetics.
    Meadows M
    FDA Consum; 2006; 40(1):6-13. PubMed ID: 16528821
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA needs more sophisticated approach to drug safety.
    Christie B
    BMJ; 2005 May; 330(7501):1166. PubMed ID: 15905236
    [No Abstract]   [Full Text] [Related]  

  • 26. General considerations for studies of the metabolism of drugs and other chemicals.
    Glocklin VC
    Drug Metab Rev; 1982; 13(6):929-39. PubMed ID: 6754317
    [No Abstract]   [Full Text] [Related]  

  • 27. Delegations of authority and organization; Office of the Commissioner--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758. PubMed ID: 10115698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant FDA approvals in 1989.
    Nightingale SL
    Am Fam Physician; 1990 Jun; 41(6):1851-2. PubMed ID: 2349910
    [No Abstract]   [Full Text] [Related]  

  • 29. History of FDA patient package insert requirements.
    Am J Hosp Pharm; 1980 Dec; 37(12):1660-1. PubMed ID: 7004180
    [No Abstract]   [Full Text] [Related]  

  • 30. The 1941 sulfathiazole disaster and the birth of good manufacturing practices.
    Swann JP
    Pharm Hist; 1999; 41(1):16-25. PubMed ID: 11623769
    [No Abstract]   [Full Text] [Related]  

  • 31. Supreme Court opens door to personal injury suits against FDA.
    Smith GR
    Healthspan; 1988; 5(7):12-4. PubMed ID: 10288659
    [No Abstract]   [Full Text] [Related]  

  • 32. The FDA ten years after the Kefauver-Harris amendments.
    Hollister LE
    Perspect Biol Med; 1974; 17(2):243-9. PubMed ID: 4591497
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA embraces risk-management approach.
    Fox JL
    Nat Biotechnol; 2003 Oct; 21(10):1120-1. PubMed ID: 14520383
    [No Abstract]   [Full Text] [Related]  

  • 34. The short happy life of the first pharmacology division of the FDA: 1935-1936.
    Farrar GE
    Clin Ther; 1989; 11(1):183-4. PubMed ID: 2655903
    [No Abstract]   [Full Text] [Related]  

  • 35. The new FDA combination products programme.
    Donawa M
    Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 37. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 38. Dirty dancing--the FDA stumbles with the Chevron two-step: a response to professor Noah.
    Lawson G
    Cornell Law Rev; 2008 Jul; 93(5):927-38. PubMed ID: 18618964
    [No Abstract]   [Full Text] [Related]  

  • 39. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 40. Of specialty interest: the Food and Drug Administration: a partner in safe practice.
    Baker K
    ORL Head Neck Nurs; 2003; 21(2):25-7. PubMed ID: 12747041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.